Cooke Shane
Known title: DirectorCIK: 0001524823
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Prothena included in Alzheimer's Day stock watchlist. Prothena was featured in a Yahoo Finance article listing four Alzheimer's drug stocks to watch on World Alzheimer's Day. This inclusion highlights the company's relevance in the neurodegenerative disease sector. The stock is currently trading near its 52-week low, with technical indicators showing a rejection at support levels.
Transaction History
| ALKS | ▼ Sell | Tax Withholding | 3,207 | $118K | 5/21/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 6,142 | — | 5/21/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 61,200 | $1.9M | 2/2/2026 | View on chart |
| ALKS | ▼ Sell | Open Market | 29,087 | $999K | 2/2/2026 | View on chart |
| ALKS | ▼ Sell | Open Market | 32,113 | $1.1M | 2/2/2026 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 4,175 | $128K | 5/31/2025 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 8,013 | — | 5/31/2025 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 6,104 | — | 6/29/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 3,175 | $77K | 6/29/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,957 | — | 7/7/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 3,098 | $93K | 7/7/2023 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 5,000 | $32K | 1/10/2023 | View on chart |
| PRTA | ▼ Sell | Open Market | 5,000 | $265K | 1/10/2023 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 5,000 | $32K | 12/12/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 332 | $20K | 12/12/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 781 | $47K | 12/12/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 3,887 | $239K | 12/12/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 875 | $50K | 11/10/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 3,870 | $217K | 11/10/2022 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 5,000 | $32K | 11/10/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 255 | $14K | 11/10/2022 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 5,000 | $32K | 10/10/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 2,324 | $129K | 10/10/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 2,676 | $151K | 10/10/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 10,000 | $481K | 9/28/2022 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 10,000 | $64K | 9/28/2022 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 15,000 | $96K | 7/20/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 15,000 | $494K | 7/20/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 7,585 | — | 6/14/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 3,945 | $107K | 6/14/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 10,000 | $166K | 5/2/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 10,000 | $292K | 5/2/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 10,000 | $166K | 4/25/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 10,000 | $279K | 4/25/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 10,000 | $166K | 4/18/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 10,000 | $289K | 4/18/2022 | View on chart |
| PRTA | ▲ Buy | Option Exercise | 5,000 | $32K | 4/11/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 3,002 | $104K | 4/11/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 1,484 | $53K | 4/11/2022 | View on chart |
| PRTA | ▼ Sell | Open Market | 514 | $19K | 4/11/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 10,000 | $166K | 4/11/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 10,000 | $293K | 4/11/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 10,000 | $166K | 4/4/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 10,000 | $282K | 4/4/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,578 | — | 12/2/2021 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,901 | $64K | 12/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Baird Highlights Growth Potential for Alkermes plc (ALKS)
Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.
Baird Highlights Growth Potential for Alkermes plc (ALKS). Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.